Beckman Coulter introduces In CEQuence, a quarterly newsletter offering technical and application information on CE-based genetic analysis
Named after the company's CEQ 2000XL DNA analysis system, the quarterly newsletter features manuscripts on cutting edge applications, descriptions of new methods, details on upcoming scientific meetings and information on Beckman Coulter Genetic Analysis product development.
Researchers interested in subscribing to In CEQuence can register on-line at the company's website (see above).
"We use this forum to share successful analytical strategies and to help our customers implement CEQ technology in their laboratories," explains Jeff Chapman, strategic market manager for Beckman Coulter. "We also invite CEQ users to contribute tips and applications information to the newsletter." Beckman Coulter is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories.
The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing that aids in patient treatment.
